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Background: Hyperlactatemia upon admission is a documented risk factor for mortality in critically ill adult patients.
However, the predictive significance of a single lactate measurement at admission for mortality in the general
population of critically ill children remains uncertain. This study evaluated the predictive value of blood lactate
levels at admission and determined the cut-off values for predicting in-hospital mortality in the critically ill pediatric
population.
Methods: We enrolled 1109 critically ill children who were admitted to a pediatric intensive care unit between July
2008 and December 2010. Arterial blood samples were collected in the first 2 hours after admission, and the lactate
levels were determined. The Pediatric Risk of Mortality III (PRISM III) scores were calculated during the first 24 hours
after admission.
Results: Of the 1109 children admitted, 115 (10.4%) died in the hospital. The median (interquartile range) blood
lactate level in critically ill children was 3.2 mmol/l (2.2-4.8). Among the children, 859 (77.5%) had a lactate
concentration >2.0 mmol/l. The blood lactate level upon admission was significantly associated with mortality
(odds ratio [OR] = 1.38; 95% confidence interval [CI], 1.30-1.46; p <0.001), even after adjustment for age, gender, and
illness severity assessed by PRISM III (OR = 1.27; p <0.001). Multivariate regression analysis showed that a high blood
lactate level (OR = 1.17; 95% CI, 1.07-1.29; p = 0.001), a high PRISM III score (OR = 1.15; 95% CI, 1.11-1.20; p <0.001),
and a low serum albumin (OR =0.92; 95% CI, 0.88-0.96; p <0.001) were independent risk factors for mortality in
critically ill children. Blood lactate achieved an area under-the-receiver-operating-characteristic curve (AUC) of 0.79
(p <0.001) for predicting mortality that was similar to that of PRISM III (AUC = 0.82; p <0.001). The p-value for a
comparison of both AUCs was 0.318. Blood lactate displayed a sensitivity of 61% and a specificity of 86% in
predicting mortality at the optimal cut-off value of 5.55 mmol/l, and the positive and negative likelihood ratios
were 4.5 and 0.45, respectively.
Conclusions: A high blood lactate level at admission is independently associated with and predictive of in-hospital
mortality in the general population of critically ill children.
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Early recognition of children who are at high risk for
mortality allows for timely changes in therapy and im-
proves the overall outcomes. Although critical care in
pediatric patients has changed dramatically over the last
several decades, there has been no consistent marker for
obtaining predictions of mortality in a general popula-
tion of critically ill children.
Lactate has been used as a marker of tissue hypoperfu-
sion and cellular hypoxia, and hyperlactatemia is signifi-
cantly associated with mortality [1-5]. Previous studies
evaluated the predictive value for mortality of both a
single lactate screening measurement at admission and
serial lactate measurements [1,6]. Hyperlactatemia in
adult patients upon admission to a general medical in-
tensive care unit was a predictive marker identifying pa-
tients who were at high risk for death [7].
Despite the publication of a few studies that investi-
gated the association of admission hyperlactatemia with
mortality in the pediatric population [6,8-16], informa-
tion on its importance in a general population of critic-
ally ill children is limited [9,14,15]. The predictive value
of a single lactate level assessed at admission, unlike ser-
ial measurements of lactate, is controversial in the gen-
eral population of critically ill children [9,14,15]. One study
of 75 patients admitted to the pediatric intensive care unit
(PICU) found that blood lactate levels assessed at 24 hours
after admission, but not at 6 hours, had better sensitivity or
specificity as a predictor of death [15]. Persistent hyperlac-
tatemia 24 hours after PICU admission is associated with
mortality, as shown in a study of 50 patients with early
hyperlactatemia (lactate >2 mmol/l within 6 hours of ad-
mission). In that study group, however, the lactate level
measured at admission did not differ significantly between
survivors and non-survivors [9]. In contrast to these re-
ports, a recently published clinical study conducted in a
retrospective cohort suggested that the blood lactate con-
centration at PICU admission predicts mortality independ-
ent of the pediatric index of mortality (PIM) [14].
The predictive significance for a single lactate meas-
urement as a screening method for children upon ad-
mission to the PICU remains uncertain. Furthermore, a
lactate level that consistently predicts mortality in the
general population of critically ill children has not been
identified. We hypothesized that the blood lactate level
upon admission to PICU is significantly associated with
mortality in critically ill children. This study evaluated
the predictive value of admission blood lactate and deter-
mined the cut-off values for predicting in-hospital mortal-
ity in the general population of critically ill children.
Methods
All children admitted to the PICU from July 2008 to
December 2010 were considered for inclusion in thestudy. The criteria for PICU admission were adopted
from guidelines for developing admission and discharge
policies for the pediatric intensive care unit [17]. The
study exclusion criteria were death in the first 2 hours
after admission and unexpectedly discharged or trans-
ferred to another hospital. The Institutional Review
Board of the Children’s Hospital of Soochow University
approved the study. Informed consent was obtained
from the parents of the children enrolled in the study.
Clinical and laboratory data collection
Clinical and laboratory data were collected on the day of
admission and included age, gender, admission diagno-
sis, illness severity assessed by the Pediatric Risk of
Mortality III (PRISM III) score, routine hematological
tests, a serum biochemical profile, and arterial blood gas
analysis. Clinical status, comorbidities, therapeutic inter-
ventions, and medication were recorded daily until hos-
pital discharge or death.
The presence of multi-organ dysfunction syndrome
(MODS) during hospitalization was determined according
to the criteria modified from the international pediatric
sepsis consensus conference [18]. The maximum number
of dysfunctional organs was 6 (cardiovascular, respiratory,
neurologic, hematologic, renal, and hepatic). Children
with dysfunction in 3 or more organs were compared to
those with fewer than 3 dysfunctional organs.
The PRISM III score
The PRISM III score was calculated to assess the illness se-
verity according to methods described in the original stud-
ies [19,20]. In brief, PRISM III was scored based on age-
related physiological parameters collected during the first
24 hours after admission, including systolic blood pressure,
heart rate, temperature, pupillary reflexes, mental status,
acidosis (pH and total CO2), pCO2, pO2, glucose, potas-
sium, creatinine, blood urea, white blood cell count, plate-
let count, and prothrombin or partial thromboplastin time.
Clinical outcome
In-hospital mortality was defined as a death occurring in
the hospital after PICU admission. A favorable outcome
was defined as a child who was discharged to home dir-
ectly from the PICU or after transfer to another depart-
ment in our hospital.
Blood sample collection and measurement
To determine the blood lactate level at admission, an ar-
terial sample was collected in the first 2 hours after a
child’s admission to the PICU. The sample was collected
directly into a tube containing anticoagulant. The blood
concentration of lactate was measured immediately
using an automatic biomedical blood gas analyzer (CCX,
NOVA Biomedical, Waltham, MA, USA) as part of a
Table 1 Comparison of demographic and clinical
characteristics and laboratory findings on admission day
between survival and non-survival critically ill children
Characteristics Survivors(n =994)
Non-survivors
(n =115) P value
Age, years 1.00 [0.29-3.00] 1.00 [0.25-3.13] 0.680
Gender, male/female 629/365 60/55 0.025
PRISM III score 3 [0–6] 12 [5–23] <0.001
MODS ≥3a, n 63 (6.3) 58 (50.4) <0.001
Need for mechanical
ventilationb, n
172 (17.3) 67 (58.3) <0.001
Laboratory findings on admission dayc
Blood lactate, mmol/l 3.10 [2.10-4.50] 6.60 [3.8-11.95] <0.001
Serum albumin, g/l 42.6 [39.6-45.8] 36.5 [30.2-42.0] <0.001
Blood glucose, mmol/l 7.12 [5.71-9.75] 10.10 [5.73-21.29] <0.001
Serum creatinine,
μmol/l 27.9 [23.20-36.78] 42.7 [27.45-67.65] <0.001
Blood urea nitrogen,
μmol/l 3.71 [2.61-5.08] 4.90 [3.69-6.71] <0.001
Serum total bilirubin,
μmol/l 6.48 [4.26-9.94] 8.03 [4.20-13.96] 0.023
Blood bicarbonate,
mmol/l
20.8 [18.0-23.9] 17.3 [12.0-21.1] <0.001
Arterial pH 7.415 [7.349-7.472] 7.359 [7.181-7.438] <0.001
Values are median [interquartile range]. Numbers in parentheses
denote percentages.
MODS, multi-organ dysfunction syndrome; PRISM III, pediatric risk of mortality III.
aMODS developed during hospitalization. bAdministration during
hospitalization. cThe first available laboratory values during the first 24 hours
after admission.
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with the electrode method, and it was expressed in milli-
mole per liter (mmol/l). The blood gas analyzer was cali-
brated every 2 hours and checked twice per day. The
detection limit for lactate was 0.5 mmol/l. The coeffi-
cient of variation was 7.5% at the low level and 5.0% at
the high level. The normal range in children is 0.5-
2.5 mmol/l. The laboratory investigators were blinded to
the sample sources and clinical outcomes.
Statistical analysis
Statistical analyses were done by using SPSS 13.0. As-
sumptions of normality and homogeneity of variance were
first checked. For continuous variables with a skewed dis-
tribution, descriptive results were expressed as medians
and interquartile ranges. The Mann–Whitney U test was
used to determine the differences between two groups,
and the Kruskal-Wallis H test was used to analyze the
differences among groups. Univariate binary and multi-
variate logistic regression analyses were performed to
investigate whether blood lactate was independently as-
sociated with in-hospital mortality. The model fit was
assessed with the Hosmer–Lemeshow goodness-of-fit
test. A non-significant value for the Hosmer-Lemeshow
Chi-square test suggests an absence of biased fit. Ana-
lysis of the area under the curve (AUC) of the Receiver
Operating Characteristic (ROC) curve was constructed
to assess the predictive strength. The nonparametric
method of Delong was used to compare significant dif-
ference between AUCs (Sigmaplot 10.0 software). Sensitiv-
ity, specificity, and positive and negative likelihood ratios
and predictive values were calculated at different cut-off
values. Optimal cut-off points to maximize both sensitivity
and specificity were also determined. All probability values
are two-sided. Differences with p values <0.05 were con-
sidered to be statistically significant.
Results
Patient characteristics
The study enrolled 1109 critically ill children, including
1045 children with a medical admission diagnosis and
64 with a surgical admission diagnosis. Of the total
1204 children admitted to the PICU during the study
period, 54 were first excluded: 37 because of refusal to
participate by parents and 17 due to failure to obtain
an arterial blood sample during the first 2 hours after
admission. Of the 1150 children who had lactate values
from arterial blood samples, 41 were excluded: 2 died
in the first 2 hours after admission, 3 were transferred
to another hospital, and 36 were unexpectedly dis-
charged due to economic reasons. Major medical ad-
mission diagnoses included respiratory diseases (39.9%),
neurological diseases (24.3%), gastrointestinal diseases
(7.3%), cardiovascular diseases (5.1%), sepsis (4.0%),hematologic/oncologic diseases (3.7%), poisoning (2.9%),
and others (7.0%). There was no significant difference be-
tween the included and excluded children with regard to
age (median [interquartile range]: 1.00 [0.25-3.00] vs 0.67
[0.25-3.00] years, p = 0.221), gender (male/female: 689/420
vs 23/18, p = 0.513), or PRISM III score (3 [2-5] vs 3 [0–7],
p = 0.740).
Of the total 1109 children, 115 (10.4%) died in the
hospital. The median time from PICU admission to
death was 48 hours (min-max range: [2.5-1176]; inter-
quartile range [24–84]) after admission. Children who
were discharged to home were considered to have a fa-
vorable outcome. The demographic and clinical charac-
teristics and laboratory findings on the day of admission
are compared between survivors and non-survivors in
Table 1. The concentration of blood lactate at admission
in surviving children was significantly higher than in
those who did not survive (p <0.001).
Comparison of data in children with different
concentrations of blood lactate
Blood lactate was detectable with a range of 0.6-
28.3 mmol/l in 1101 samples. For undetectable levels,
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of 0.4. The median blood lactate level measured in the
first 2 hours after admission in critically ill children
was 3.2 mmol/l. Among the children, 859 (77.5%) had
a lactate concentration >2.0 mmol/l, including 485
(43.7%), 204 (18.4%), 79 (7.1%), 34 (3.1%) and 57
(5.1%) who had lactate concentrations of 2.1-4.0, 4.1-
6.0, 6.1-8.0, 8.1-10.0 and greater than 10.0 mmol/l,
respectively.
A comparison of the demographic and clinical char-
acteristics and the laboratory findings collected on the
day of admission among children is shown in Table 2.
The incidence of mortality in critically ill children was
significantly associated with increased blood lactate
levels (p <0.001). A significant increase in the PRISM
III scores (p <0.001) and the blood glucose concentra-
tions (p <0.001) was associated with increases in the
blood lactate levels. In contrast, the blood bicarbonate con-
centrations (p <0.001) and arterial pH values (p <0.001)
were significantly decreased with increases in the blood
lactate levels.Table 2 Comparison of demographic and clinical characterist
children with different concentrations of blood lactate
Admission blood lactate, mmom/l 0.0-2.0 2.1-4.0
n 250 485
Age, years 1.75 [0.58-4.00] 1.00 [0.33-3.00] 0.67
Gender, male/female 163/87 304/181
PRISM III score 3 [0–6] 3 [0–6] 3
MODS ≥3a, n 11 (4.4) 24 (4.9)
Mechanical ventilationb, n 29 (11.6) 95 (19.6)
In-hospital mortality, n 7 (2.8) 27 (5.6)






















Values are median [interquartile range]. Numbers in parentheses denote percentag
BUN, blood urea nitrogen; MODS, multi-organ dysfunction syndrome; PRISM III, pedi
aMODS developed during hospitalization. bAdministration during hospitalization. cTAssociation of blood lactate level with in-hospital
mortality
Univariate binary and multivariate logistic regression
analyses were performed to investigate whether the
blood lactate level at admission was independently asso-
ciated with in-hospital mortality (Table 3). Age, gender,
illness severity as assessed by the PRISM III score, and
laboratory findings collected on the day of admission
that were potentially associated with in-hospital mortal-
ity were included in the analyses. The following factors
were significantly associated with in-hospital mortality
in the unadjusted binary logistic regression analysis:
gender, PRISM III score, blood lactate level, albumin,
glucose, creatinine, urea nitrogen and bicarbonate, and
arterial pH value. The odds for in-hospital mortality in-
creased by 38%, for every 1 mmol/l increase in blood
lactate (OR = 1.38; 95% CI, 1.30-1.46; p <0.001). The
association of blood lactate levels with in-hospital mor-
tality remained significant after adjusting for age, gen-
der, and the severity of illness as assessed by the PRISM
III score (OR = 1.27; 95% CI, 1.19-1.35; p <0.001).ics and laboratory findings on admission day among
4.1-6.0 6.1-8.0 8.1-10.0 >10.0 P value
204 79 34 57
[0.25-2.00] 0.54 [0.25-3.50] 0.42 [0.17-1.25] 0.92 [0.33-3.00] <0.001
122/82 60/19 9/25 31/26 <0.001
[0.75-7] 5 [2–11] 8 [4–15.75] 14 [6–24] <0.001
20 (9.8) 20 (25.3) 12 (35.3) 34 (59.6) <0.001
48 (23.5) 23 (29.1) 13 (38.2) 31 (54.4) <0.001
18 (8.8) 14 (17.7) 9 (26.5) 40 (70.2) <0.001
42.0 40.2 39.6 32.8
<0.001
39.9-45.7] [34.2-44.5] [35.9-43.15] [29.0-40.0]
7.60 8.90 11.35 16.27
<0.001
.15-11.37] [6.65-14.02] [7.40-21.21] [10.78-27.90]
27.8 31.7 37.6 62.4
<0.001
23.1-37.5] [22.8-48.8] [25.9-60.1] [43.0-79.7]
3.59 4.46 4.87 4.72
<0.001
2.35-5.12] [2.85-6.69] [3.04-6.48] [3.80-6.92]
7.01 9.43 4.91 6.71
<0.001
.73-11.69] [6.18-17.28] [3.33-8.89] [4.03-12.61]
20.8 17.7 15.9 11.5
<0.001
17.9-23.8] [14.8-21.4] [11.7-20.4] [6.6-15.3]
7.390 7.368 7.267 7.177
<0.001
.332-7.456] [7.304-7.464] [7.141-7.338] [7.005-7.272]
es.
atric risk of mortality III.
he first available laboratory values during the first 24 hours after admission.
Table 3 Univariate and multivariate logistic regression






OR (95% CI) P value OR (95% CI) P value
Age 1.02 (0.96-1.08) 0.542 1.06 (0.96-1.16) 0.249
Gender 1.58 (1.07-2.33) 0.021 1.11 (0.63-1.97) 0.715
PRISM III score 1.18 (1.15-1.21) <0.001 1.15 (1.11-1.20) <0.001e
Laboratory findings on admission dayf
Lactate 1.38 (1.30-1.46) <0.001a 1.17 (1.07-1.29) 0.001b,c
Albumin 0.86 (0.83-0.89) <0.001 0.92 (0.88-0.96) <0.001d
Glucose 1.11 (1.08-1.13) <0.001 1.00 (0.96-1.03) 0.829
Creatinine 1.01 (1.00-1.01) <0.001 0.99 (0.98-1.01) 0.428
Urea nitrogen 1.05 (1.01-1.08) 0.006 1.03 (0.94-1.12) 0.556
Total bilirubin 1.01 (1.00-1.01) 0.010 1.01 (0.99-1.01) 0.080
Bicarbonate 0.89 (0.87-0.93) <0.001 1.03 (0.98-1.08) 0.217
Arterial pH 0.01 (0.00-0.03) <0.001 0.54 (0.06-4.75) 0.580
CI, confidence interval; OR, odds ratio; PRISM III, pediatric risk of mortality III.
The p value of the Hosmer-Lemeshow goodness-of-fit test for the multivariate
logistic regression model was 0.611.
aThe association of blood lactate with in-hospital mortality remained significant
after adjustment for age, gender, and the PRISM III score (OR = 1.27; 95% CI,
1.19-1.35; p <0.001). bThe association of the blood lactate level with in-hospital
mortality remained significant after adjustment for serum albumin and the PRISM
score (OR = 1.17; 95% CI, 1.09-1.26; p <0.001). cOdds ratio represents the increase
in risk per 1 mmom/l increase in lactate concentration. dOdds ratio per 1 g/l
increase in albumin level. eOdds ratio per 1-point increase in PRISM III score.
fThe first available laboratory values during the first 24 hours after admission.
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lactate (OR = 1.17; 95% CI, 1.07-1.29; p = 0.001), serum
albumin (OR per 1 g/l increase = 0.92; 95% CI, 0.88-
0.96; p <0.001), and the PRISM III score (OR per 1-point
increase = 1.15; 95% CI, 1.11-1.20; p <0.001) as independ-
ent factors that were significantly associated with in-
hospital mortality in critically ill children. The Hosmer-
Lemeshow goodness-of-fit test for the multivariate logistic
regression model was not significant (p = 0.611), indicat-
ing that the model adequately fits the data. Furthermore,
the association between blood lactate levels and in-
hospital mortality remained significant after adjustingTable 4 Predicting performance of admission blood lactate an
AUC 95% CI P
Admission blood lactate 0.79 0.74-0.84 <
PRISM III score 0.82 0.78-0.86 <
Blood lactate combined with PRISM III 0.86 0.83-0.90 <
P value (comparison of the difference between AUCs)
p = 0.318 (between blood lactate and PRISM III)
p = 0.135 (between blood lactate combined with PRISM III and PRISM III alon
p = 0.018 (between blood lactate combined with PRISM III and blood lactate
AUC, area under the receiver-operating-characteristic curve; CI, confidence interval;for the PRISM III score and serum albumin (OR = 1.17;
95% CI, 1.09-1.26; p <0.001).
Ability of blood lactate level to predict in-hospital
mortality
The predictive ability of blood lactate levels from all
children admitted to the PICU (n = 1109) for in-hospital
mortality (n = 115) was assessed (Table 4). The level of
blood lactate was predictive of in-hospital mortality and
achieved AUC of 0.79 (95% CI, 0.74-0.84; p <0.001). This
AUC is similar to the PRISM III score (AUC = 0.82; 95%
CI, 0.78-0.86; p <0.001) for predicting the in-hospital
mortality. The p-value for comparison of both AUCs
was 0.318. Combining blood lactate levels with the
PRISM III score improved the predictive performance
(AUC = 0.86; 95% CI 0.83-0.90; p <0.001), which is bet-
ter than blood lactate alone (p = 0.018), but not signifi-
cantly better than PRISM alone (p = 0.135). Figure 1
shows the ROC curves and the AUC of the blood lactate
level at admission, the PRISM III score, and the combin-
ation of the blood lactate with the PRISM III score for pre-
dicting the in-hospital mortality of critically ill children.
The sensitivity and specificity of the blood lactate
levels and PRISM III scores at the optimal cut-off value
to predict in-hospital mortality are shown in Table 4.
Blood lactate displayed a sensitivity of 61% and a specifi-
city of 86% at the optimal cut-off value of 5.55 mmol/l.
The positive and negative likelihood ratios were 4.5 and
0.45, respectively. The PRISM III score displayed a sensi-
tivity of 68% and a specificity of 82% for predicting in-
hospital mortality at the optimal cut-off score of 7.5, and
the positive and negative likelihood ratios were 3.8 and
0.39, respectively.
We also calculated the sensitivity and specificity of dif-
fering concentrations of blood lactate to predict in-
hospital mortality in critically ill children (Table 5). At the
cut-off value of >2.0 mmol/l, blood lactate displayed a sen-
sitivity of 94% and a specificity of 24% for predicting in-
hospital mortality, and the positive and negative likelihood
ratios were 1.2 and 0.25, respectively. The specificity in-
creased to 98%, and the positive likelihood ratio increasedd PRISM III for in-hospital mortality
value Optimal cut-off value Sensitivity Specificity
0.001 5.55 mmol/l 61% 86%




PRISM III, pediatric risk of mortality III.
Figure 1 Receiver operating characteristic curves for the ability
of blood lactate, PRISM III, and blood lactate combined with
PRISM III to predict in-hospital mortality in generally critically
ill children (n = 1109). The area under the receiver operating
characteristic curve for blood lactate, PRISM III, and blood lactate
combined with PRISM III were 0.79, 0.82 and 0.86, respectively, with
a Hosmer-Lemeshow goodness-of-fit p value >0.05.
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sensitivity decreased to 34%. The OR values of blood lac-
tate at the levels above the set cut-off points are shown in
Table 5.
In addition, 65.0% children had a lactate concentra-
tion >2.5 mmol/l in the study, which is suggested to be
an optimal cut-off value for lactate to predict deterior-
ation and mortality in adult patients [1]. Blood lactate
displayed a sensitivity of 90% and a specificity of 38% to
predict in-hospital mortality at this cut-off value in crit-
ically ill children.
Discussion
This study provides data on blood lactate concentrations
in critically ill children and demonstrates that the bloodTable 5 Odds ratio, sensitivity, and specificity for admission b
hospital mortality in critically ill children
Admission blood lactate mmom/L, ORa (95% CI) P value
>2.00 4.95 (2.27-10.78) <0.001
>4.00 5.68 (3.72-8.68) <0.001
>6.00 10.02 (6.59-15.23) <0.001
>8.00 16.79 (10.37-27.19) <0.001
>10.00 30.59 (16.55-56.53) <0.001
CI, confidence interval; LR+, likelihood ratio positive; LR-, likelihood ratio negative; O
aOdds ratios of blood lactate at the levels above the set cut-off points.lactate level upon admission to a general medical PICU
is significantly associated with in-hospital mortality. A
high blood lactate level at PICU admission is predictive
of in-hospital mortality in critically ill children.
Many studies have demonstrated that either admission
lactate or peak lactate concentration is associated with
mortality in adults [1,4,21,22]. To our knowledge, a lim-
ited number of studies verified the use of hyperlactate-
mia as a prognostic index in critically ill children who
are admitted to the PICU [9,14,15]. Our results are in
line with recently published findings that suggest that
blood lactate concentration upon admission to PICU is
predictive of mortality, independent of PIM2. Patients
with contemporaneous blood lactate and PIM2 measure-
ments at PICU admission were enrolled in a retrospect-
ive cohort study [14]. Our study was conducted in a
large mixed cohort of critically ill children. Blood sam-
ples were prospectively collected for assessing the blood
lactate concentration. The observation that the extent of
absolute hyperlactatemia is strongly linked with mortal-
ity independent of illness severity indicates that blood
lactate is a useful early predictor in identifying critically
ill children who are at high risk of death in the pediatric
intensive care setting.
The discrepancy between our data and the data from
two studies performed on a small number of patients
might most likely be attributed to the small sample size
in the previous studies [9,15]. However, the possibility
that the discrepancy might be caused by differences in
the course of the clinical illness at PICU admission must
be considered. Our study included a higher proportion
of patients (859 of 1109, 77%) with a high level of blood
lactate at admission (>2 mmol/l), compared to a previ-
ous publication in which high values were found in only
50 of the 705 studied children at admission (7%) [9]. To-
gether with the high overall mortality of 10.6% in the
present study, this finding implies that children might be
admitted later to our PICU, most likely because of de-
layed PICU transfers.
One contribution of this study is the use of PRISM III
to control for the severity of the illness. The PRISM III
score is a valid measure of illness severity in the firstlood lactate at different concentrations to predict in-
Sensitivity Specificity LR+ LR– PV+ PV-
94% 24% 1.2 0.25 0.55 0.80
70% 70% 2.4 0.42 0.70 0.70
55% 89% 5.1 0.51 0.84 0.66
43% 96% 10.1 0.60 0.91 0.63
34% 98% 19.8 0.67 0.95 0.60
R, odds ratio; PV+, positive predictive value; PV-, negative predictive value.
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of a child during the early admission period [19,23]. Pre-
vious studies suggest that PRISM III is an important tool
in predicting mortality and clinical outcomes in the
pediatric population [20,24,25]. The association of ad-
mission blood lactate with in-hospital mortality in this
study was independent of age, gender, and the severity
of illness as assessed by the PRISM III score. The ROC
curve analysis in the present study showed that the
prognostic accuracy of blood lactate for in-hospital mor-
tality (AUC = 0.79) was similar to that of the PRISM III
score (AUC = 0.82). Because blood lactate at admission
and the PRISM III score obtained within the first
24 hours after PICU admission are comparable in pre-
dicting mortality, we recommend assessing mortality risk
with blood lactate at admission because it is simple to
use.
Previous studies suggest that there is a confounding
relationship between hyperlactatemia and hyperglycemia
in nondiabetic critically ill patients [26]. In the present
study, there was a significant increase in the blood glu-
cose concentration with an increase in the blood lactate
levels, suggesting that hyperglycemia is significantly cor-
related with hyperlactatemia. We further demonstrated
that hyperlactatemia was associated with an increased
mortality risk, regardless of the presence of hypergly-
cemia. This finding suggests that hyperglycemia did not
confound the association between the elevated blood
lactate level and mortality in this study. In contrast, al-
though hyperglycemia had a significant univariate asso-
ciation with mortality risk, when adjusted for concurrent
hyperlactatemia and/or other potential risk factors,
hyperglycemia was not a significant predictor of mortal-
ity risk in critically ill children.
The accumulation of lactic acid in the blood is gener-
ally associated with metabolic acidosis [12,27]. This find-
ing raises the question of whether it is possible that the
association of hyperlactatemia with mortality could be at
least partially attributed to the occurrence of metabolic
acidemia. We demonstrated that hyperlactatemia is sig-
nificantly associated with in-hospital mortality in critic-
ally ill children, even after adjusting for arterial pH and
blood bicarbonate.
This study was designed to determine the optimal re-
lationship between the sensitivity and specificity of blood
lactate assessment in predicting mortality and to set ap-
propriate cut-off values for predicting in-hospital mor-
tality. A systematic review conducted on studies of adult
patients suggests that all patients with a lactate at admis-
sion above 2.5 mmol/l should be closely monitored for
signs of deterioration [1]. In our study, 65.0% of the chil-
dren had a lactate concentration >2.5 mmol/l. Blood lac-
tate displayed a sensitivity of 90% and a specificity of
38% in predicting in-hospital mortality at 2.5 mmol/l.Specificity is one of the main characteristics of a predict-
ive marker. A test with high sensitivity and low specifi-
city carries the risk of many false positives. In the
present study, an optimal cut-off for predicting in-
hospital mortality in critically ill children appears to be a
blood lactate level of 5.55 mmol/l, which has a sensitivity
of 61% and a specificity of 86%. Our findings were simi-
lar to the results of a previous study conducted in chil-
dren who were admitted to the PICU with a diagnosis of
septic shock, where a lactate value of more than
5 mmol/l was an accurate predictor of death [28]. Our
data, together with previous data, suggest that all critic-
ally ill children with high blood lactate at admission
should be closely monitored for signs of clinical deteri-
oration and children with low lactate levels should be
considered for further monitoring of blood lactate, since
serial lactate values may provide better prognostic infor-
mation [1,6,9,29].
The limitations of the present study include a tem-
poral mismatch in evaluating mortality indicators. We
compared the prognostic performance of a lactate value
obtained within 2 hours of admission to a PRISM III
score, which considers a range of values and includes
the worst values obtained in the first 24 hours of admis-
sion. The prognostic accuracy of the combination of
blood lactate level and PRISM III score was not signifi-
cantly better than the use of PRISM III alone (p = 0.135),
which might be explained by the discrepancy in the time-
scales for these two methods. Notably, the primary aim of
the study was to evaluate the predictive value of blood lac-
tate, when measured as a screening method at admission,
to predict mortality in critically ill children. The blood
samples for lactate measurements were collected only
within the first 2 hours of admission. Thus, serial changes
in the lactate levels during the first 24 hours of admission
were not evaluated. Trends in lactate concentration over
time reflect the clinical response of patients to resuscita-
tion. Serial measurements of lactate levels might improve
the sensitivity and specificity of this prognostic test [29].
Further studies are needed to investigate the trends in the
changes of lactate values and explore whether the addition
of the highest lactate value in the first 24 hours to the
PRISM III evaluation improves the prediction of mortality
in the critically ill pediatric population.
A second limitation of this study is that the criteria for
PICU admission vary widely. Our results might be
biased by the fact that we conducted a single-center
study. In our study, 77% of the children had an admis-
sion lactate level above 2 mmol/l, and 10.6% of the chil-
dren died during the hospital stay. However, only 32% of
children with an admission lactate level between 6 and
10 mmol/l had been mechanically ventilated. Our data
imply that children might be admitted later to the PICU
and received less aggressive treatment in our unit. These
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health care systems in which children are admitted earl-
ier in their critical illness course and are managed more
aggressively. A multicenter study is necessary to confirm
our findings.
A third limitation of the study is that during the blood
collection period, a substantial number of children re-
ceived treatment with common PICU therapeutic inter-
ventions such as epinephrine. Epinephrine is known to
affect lactate levels [30,31]. Unfortunately, we were un-
able to include these data in our multivariate analyses
because we did not have information concerning thera-
peutic interventions for all children during their trans-
fers to the PICU.
Conclusions
Our study indicates that the blood lactate levels on ad-
mission to the PICU were significantly associated with
mortality in critically ill children, even after adjusting for
age, gender, and illness severity. A high level of blood
lactate upon admission was independently predictive of
in-hospital mortality in the pediatric population. These
findings extend the knowledge of blood lactate as a clin-
ical biomarker of mortality in critical illness.
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